SteriLance Medical Unveils the Onestep Lancing Device in Spain
SteriLance Medical has made a groundbreaking entrance into the Spanish healthcare market by launching the Onestep lancing device and complementary SoftSense lancets on July 10, 2025. This marks a significant step in their European expansion, providing innovative solutions for blood sampling to enhance patient comfort and convenience.
The Onestep Device: A Game Changer
The Onestep device is the world’s first cap-free lancing tool, designed with a patented technology called Total Path Control™ (TPC). Its unique four-step process allows for a hidden needle that remains concealed throughout the sampling process, resulting in a product that not only minimizes pain but also streamlines usability. In fact, the device requires approximately 70% fewer actions compared to traditional lancing devices.
Features of Onestep
- - Innovative Needle Loading: Users can load and extract the SoftSense lancet in a single action by simply turning the protective cap, eliminating the need to remove the entire cap from the device.
- - Streamlined Process: With Onestep, users can perform blood sampling in four easy steps—insert, twist, press, and eject—making it remarkably simple and user-friendly.
- - Vertical Drive System: The TPC™ technology guides the needle directly into the skin, significantly reducing vibrations and tissue trauma, thus providing a near pain-free experience.
- - Hidden Needle Mechanism: The design ensures that the needle is hidden throughout the process, lessening patient anxiety and decreasing the risk of accidental injuries.
In a recent evaluation with approximately 30 patients undergoing regular tests, 92% reported experiencing “little or no pain,” while 87% felt a heightened sense of confidence thanks to the device's design that prevents them from seeing the needle.
Addressing Diabetes Challenges in Spain
With an estimated 5.1 million adults in Spain living with diabetes, a figure that represents one of the highest prevalence rates in Europe, easy-to-use and painless devices like the Onestep are crucial for improving adherence to daily self-monitoring. Effective diabetes management heavily relies on regular blood sampling, making innovative solutions indispensable.
Availability and Future Plans
The Onestep device and SoftSense lancets are now available in select pharmacies and online platforms across Spain. SteriLance Medical plans to extend distribution throughout Europe in the upcoming months, ensuring that more patients can access these vital tools.
Regulatory Compliance
Both Onestep and SoftSense are compliant with CE-MDR and ISO 13485 certifications, which guarantees their safety and effectiveness for frequent home blood sampling.
For further information about the Onestep lancing device and its features, please visit
SteriLance's official product page.
For media inquiries or distribution questions, contact [email protected]